AI Protein Engineering

Predict which variants will stabilize. Before you synthesize.

Scala Biodesign's stability AI scores your full mutation space from sequence alone, so your wet-lab budget goes to the candidates that matter.

Variant Stability Scores live run
Variant Mutations dG (kcal/mol) Class
Var-A01 2 -1.4 Stable
Var-A02 3 +0.3 Marginal
Var-A03 4 -2.1 Stable
Var-A04 2 +1.8 Unstable
Var-A05 5 -0.9 Stable
Var-A06 1 +0.7 Marginal

Wet-lab cycles are expensive. Most mutations fail before you learn why.

70%
of designed variants show no measurable stability improvement in the first round of synthesis
4-6 wk
average turnaround per synthesis-and-test cycle in industrial enzyme programs

Computational pre-screening shifts the economics. Most available tools require a solved structure, a trained bioinformatician, or both. Scala works from sequence alone.

What the platform does

01

Sequence-only stability scoring

Submit a FASTA sequence. Receive per-position and per-variant delta-G scores without needing a crystal structure or AlphaFold prediction as input.

02

Combinatorial variant scanning

Score all single-point mutants, or define a combinatorial panel of up to 10,000 variants and rank them by predicted stability improvement in a single run.

03

Epistatic coupling analysis

Identify mutation pairs where the combined effect differs from the sum of individual effects, reducing costly surprises during multi-site engineering campaigns.

From sequence to ranked shortlist in three steps

01

Upload

Paste your sequence or upload a FASTA file. Define the mutation positions you want to probe or let the scanner find them automatically.

02

Score

Our stability model evaluates each variant, combining physics-informed energy estimation with learned sequence-fitness representations.

03

Shortlist

Download a ranked CSV. Filter by stability class, mutation count, or positional diversity. Bring only your top candidates to synthesis.

Early results from our pilot program

3.2x
fewer variants taken to synthesis
78%
of top-3 model picks included the actual high-performer
6 wks
shaved from a typical mutation campaign

Based on internal benchmark across 47 protein families from our early-access pilot program (Q3-Q4 2025). Individual results vary by protein family and mutation space.

What our research partners say

Scala cut the list of variants we needed to synthesize by 60 percent on our first pilot run. We went into the wet lab with 8 candidates instead of 140.

Dr. Yael Barak, Senior Protein Engineer
Specialty enzymes group
Early-access pilot program participant

The mutation landscape output gave our team a shared framework for prioritization that we did not have before. Fewer arguments, faster decisions going into synthesis.

Marcus Hofer, Head of Computational Chemistry
Pharma R&D group
Early-access pilot program participant

Ready to cut your mutation screening time?

Join the early-access program and run your first protein through Scala within a week.